Mei-Lun Wang

Dr. Wang joined Alladapt in 2021. Prior to joining Alladapt, Dr. Wang was Director of Clinical Development in Immunology at Janssen, where she focused on clinical oversight and strategic planning for late-phase programs in inflammatory bowel disease (IBD). Prior to Janssen, she worked at GSK across all phases of clinical development, guiding clinical strategy and execution of programs in ulcerative colitis (UC), rheumatoid arthritis (RA), psoriasis (PsO), renal transplantation, and pediatric systemic lupus erythematosus (SLE).

Dr. Wang holds a BA from Cornell University and an MD from the University of Pennsylvania School of Medicine. She completed her residency in Pediatrics at the University of Washington School of Medicine, where she also served as Chief Pediatric Resident. Dr. Wang completed her fellowship in Pediatric Gastroenterology at the Children's Hospital of Philadelphia (CHOP), where she served as an attending physician for 11 years, and established a basic/translational research program in Eosinophilic Esophagitis (EoE).